Evidence map›Paper›PMID 23017329›Full record

Trial reportRespiratory physiology & neurobiology2013

Effects of clonidine on breathing during sleep and susceptibility to central apnoea.

Abdul Ghani Sankri-Tarbichi, Kevin Grullon, M Safwan Badr

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Respiratory physiology & neurobiology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Comparison of Low and High Dose Clonidine for Infants Admitted to the Neonatal Intensive Care Unit.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  4. Sleep apnea pathophysiology.Sleep & breathing = Schlaf & Atmung · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Complex sleep apnea.Current treatment options in neurology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Abdul Ghani Sankri-TarbichiSleep Research Laboratory, John D. Dingell Veterans Affairs Medical Center, Wayne State University, 4646 John R, Detroit, MI 48201, USA. atarbich@med.wayne.edu
Kevin Grullon
M Safwan Badr
Wayne State University · US

Funding

CENTRAL SLEEP APNEA--ROLE OF LONGTERM FACILITATIONR01HL053443 · NHLBI · WAYNE STATE UNIVERSITY · PI BADR, M.SAFWAN · 1999 to 2009
$1.8M
SLEEP APNEA--DETERMINANTS AND CONSEQUENCESK24HL004174 · NHLBI · WAYNE STATE UNIVERSITY · PI BADR, M.SAFWAN · 1999 to 2008
$718k
Breathing Instability and Upper Airway Obstruction During Sleep: Effect of AgingI01CX000194 · VA · JOHN D DINGELL VA MEDICAL CENTER · PI BADR, M.SAFWAN · 2009 to 2013
–
CSRD VA I01 CX000194NHLBI NIH HHS K24 HL004174NHLBI NIH HHS R01 HL053443
6 · The paper itself

Abstract

unlabelledWe hypothesized that administration of clonidine would decrease the hypocapnic apnoeic threshold (HAT) and widen the CO(2) reserve during non-REM sleep.

methodsTen healthy subjects (4 females) (age 22.3 ± 3.0 years; BMI 25.5 ± 3.4 kg/m(2)) were randomized to receive placebo or 0.1 mg/45 kg of clonidine on 2 separate nights. Ventilation and upper airway resistance were monitored during wakefulness and sleep. Two separate experiments were performed: Protocol 1 (n=8), CO(2) reserve, HAT and HcVR were determined using non-invasive hyperventilation (NIV) to induce hypocapnia for at least 3 min; Protocol 2 (n=6), peripheral hypocapnic ventilatory response (HcVR) was determined by NIV using short (3 breaths) hyperventilation.

resultsClonidine decreased the systolic blood pressure by 12 ± 10 mmHg but did not affect baseline ventilation or upper airway resistance during wakefulness or sleep. Protocol (1), clonidine was associated with decreased HAT relative to placebo (37.3 ± 3.3 mmHg vs. 39.7 ± 3.4 mmHg, P<0.05), increased CO(2) reserve (-3.8 ± 1.3 mmHg vs. -2.8 ± 1.2 mmHg, P<0.05), and decreased HcVR (1.6 ± 0.6 L/min/mmHg vs. 2.5 ± 1.3 L/min/mmHg, P<0.05). Protocol (2), administration of clonidine did not decrease peripheral HcVR compared to placebo (0.5 ± 0.3 L/min/mmHg vs. 0.7 ± 0.3 L/min/mmHg, P=NS).

conclusionClonidine is associated with diminished susceptibility to hypocapnic central apnoea without significant effect on ventilation or upper airway mechanics. Reduced susceptibility to hypocapnic central apnoea is not explained by the peripheral chemoreceptor pathway. This suggests a central rather than a peripheral effect of clonidine on the susceptibility to hypocapnic central apnoea.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAdultAirway ResistanceCarbon DioxideClonidineDisease SusceptibilityDouble-Blind MethodElectroencephalographyElectromyographyFemaleHumansHyperventilationMalePulmonary VentilationRespirationSleepAdrenergic alpha-2 Receptor AgonistsCarbon DioxideClonidine

Identifiers

PMID23017329
PMCPMC4757488
OpenAlexW1999860643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.